Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies
Open Access
- 28 March 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1386929
Abstract
CDK8 is an important member of the cyclin-dependent kinase family associated with transcription and acts as a key “molecular switch” in the Mediator complex. CDK8 regulates gene expression by phosphorylating transcription factors and can control the transcription process through Mediator complex. Previous studies confirmed that CDK8 is an important oncogenic factor, making it a potential tumor biomarker and a promising target for tumor therapy. However, CDK8 has also been confirmed to be a tumor suppressor, indicating that it not only promotes the development of tumors but may also be involved in tumor suppression. Therefore, the dual role of CDK8 in the process of tumor development is worth further exploration and summary. This comprehensive review delves into the intricate involvement of CDK8 in transcription-related processes, as well as its role in signaling pathways related to tumorigenesis, with a focus on its critical part in driving cancer progression.Keywords
Funding Information
- Natural Science Foundation of Hunan Province (2021JJ30610 2020JJ4539)
- Health Commission of Hunan Province (202104101985)
- Hengyang Science and Technology Board (202150064015)
This publication has 112 references indexed in Scilit:
- Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate CancerThe American Journal of Pathology, 2022
- FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targetsCancer Letters, 2020
- Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila2019
- Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinomaEuropean Archives of Oto-Rhino-Laryngology, 2017
- The paradoxical role of IL-10 in immunity and cancerCancer Letters, 2015
- Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathwayCancer Letters, 2015
- Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stressCellular and Molecular Life Sciences, 2014
- Emerging roles of Cdk8 in cell cycle controlBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2013
- Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1Biochemical and Biophysical Research Communications, 2011
- SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor geneCell, 1993